Breast
Breast Cancer Resource Center
Latest News
American Society of Breast Surgeons Recommends Genetic Testing for All Patients With Breast Cancer
Featured
Treatment Guidelines in Cancer: Assessing Industry Influence on Recommendations
More News
American Society of Breast Surgeons Recommends Genetic Testing for All Patients With Breast Cancer
Birinapant Found to Enhance Antitumor Activity of CAR-T in Solid Tumor Models
CML
Chronic Myeloid Leukemia Resource Center
Latest News
Prototype Intervention Increased Adherence to TKIs in CML
Featured
Patients With CP-CML Deemed Less Likely to Continue Taking Generic Imatinib
More News
Polymorphism in
HSD3B1
as a Potential Prognostic Biomarker in Prostate Cancer
OS and PFS End Points Not Met in Phase 3 Trial of Pembrolizumab in Advanced HCC
GI
Gastrointestinal Cancer Resource Center
Latest News
OS and PFS End Points Not Met in Phase 3 Trial of Pembrolizumab in Advanced HCC
Featured
Treatment Guidelines in Cancer: Assessing Industry Influence on Recommendations
More News
OS and PFS End Points Not Met in Phase 3 Trial of Pembrolizumab in Advanced HCC
Direct-Acting Antiviral Therapy and Recurrence of Hepatitis C-Related Hepatocellular Carcinoma
GYN
Gynecologic Cancer Resource Center
Latest News
New Epigenetic Cervical Cancer Test Outperforms Pap and HPV Testing
Featured
Aspirin and Liver, Ovarian Cancers
More News
New Epigenetic Cervical Cancer Test Outperforms Pap and HPV Testing
HPV-Related Cancer Risk Elevated in Hispanics With HIV
Lung
Lung Cancer Resource Center
Latest News
No Benefit Observed With Osimertinib Plus Durvalumab in
EGFR
-Mutated NSCLC
Featured
Treatment Guidelines in Cancer: Assessing Industry Influence on Recommendations
More News
No Benefit Observed With Osimertinib Plus Durvalumab in
EGFR
-Mutated NSCLC
An Exome-Based Model to Predict Benefit of ICIs in NSCLC
Multiple Myeloma
Multiple Myeloma Resource Center
Latest News
The Incidence of Some Obesity-Related Cancers Is Increasing Among Young Adults
Featured
Lenalidomide Maintenance Therapy for Multiple Myeloma
More News
Takeda to Collaborate With MSKCC on CAR-T Therapies for Multiple Myeloma
Depth of Response Translates Into Real-World Benefit in Multiple Myeloma
Prostate
Prostate Cancer Resource Center
Latest News
Polymorphism in
HSD3B1
as a Potential Prognostic Biomarker in Prostate Cancer
Featured
Treatment Guidelines in Cancer: Assessing Industry Influence on Recommendations
More News
Polymorphism in
HSD3B1
as a Potential Prognostic Biomarker in Prostate Cancer
Investigational Antiandrogen Drug Delays Metastasis in CRPC
RCC
Renal Cell Carcinoma Resource Center
Latest News
Tivozanib Offers Superior Outcomes in Refractory Metastatic Renal Cell Carcinoma
Featured
Evidence of the Role of Circulating Insulin in Renal Cell Carcinoma Risk
More News
Tivozanib Offers Superior Outcomes in Refractory Metastatic Renal Cell Carcinoma
First-Line Pembrolizumab Shows Promise in Non-Clear Cell RCC
Skin
Skin Cancer Resource Center
Latest News
Imatinib Found to Be Effective in Unresectable Dermatofibrosarcoma Protuberans
Featured
A Common Factor Links Mechanisms of Acquired Resistance to Melanoma Treatment
More News
Imatinib Found to Be Effective in Unresectable Dermatofibrosarcoma Protuberans
Specific T Cells Play Key Role in Melanoma-Immune Equilibrium
More
Bladder Cancer
Bone Cancer
Brain Cancer
Chronic Lymphocytic Leukemia
Endocrine Cancer
General Oncology
Head and Neck Cancer
Hematologic Cancer
Lymphoma
Pancreatic Cancer
Pediatric Cancer
Practice Management
Sarcoma
Side Effect Management
Supportive Care
Urologic Cancers
More
HEADLINES
REGIMENS
DRUGS
CONFERENCES
Clinical Resources
TOOLS
Multimedia
CME
JOBS
GET THE APP
•
SUBMIT CASES
Cancer Therapy Advisor Facebook
Cancer Therapy Advisor Twitter
Cancer Therapy Advisor LinkedIn
Cancer Therapy Advisor
>
Login
Bleeding Disorder Treatments: Hemophilia B
Treatment options for Hemophilia B.
{{{error}}}
{{error}}
{{{ form.title }}}
*Required
{{ field.label }}
{{ field.label }}
{{ option.label }}
{{ field.label }}
{{ field.label }}
{{ field.additionalLabel }}
By registering you consent to the collection and use of your information to provide the products and services you have requested from us and as described in our
privacy policy
and
terms and conditions.
{{{ field.label }}}
{{{field.value}}}
{{{field.value}}}
{{ form.postButtonLabel }}
Terms And Conditions
|
Privacy Policy